1Swerdlow SH, Campo E, Harris NL, et al. World Health Or ganization classification of tumours of the haematopoietic and lymphoid tissues. Lyon: Interational Agency for Research on Cancer, 2008,31-64.
3Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for re vision of the World Health Organization diagnostic criteria for polycythemia vera, essential thromboeythemia, and primary my- elofibrosis:recommendations from an ad hoc international expert panel. Blood, 2007,110:1092.
5Georgii A, Buesche G, Kreft A. The histopathology of chronic myeloprolerative diseases. Baillieres Clin Haematol, 1998, 11: 721.
6Thiele J, Kvasnicka HM, Orazi A. Bone marrow histopathology in myeloproliferative disorders current diagnostic approach.. Semin Hematol, 2005,42: 184.
9Thiele J, Kvasnicka HM. Diagnostic differentiation of essential thrombocythaemia from thrombocythaemia associated with chronic idiopathic myelofirosis by discriminate analysis of bone marrow features-a clinicopathological study on 272 patients. Histol Histopathol, 2003,18 : 93.
二级参考文献37
1Jaffe ES,Harris NL,Stein H,ff a1.World Health Organization Classification of Tumours—Pathology and genetics of tumours of haematopoieticand lymphoid tissuses.Lyon:International Agency for Research on Cancer(IARC)2001.
2Tiele J,KvasnickaHM.Pathologe,2001,22(6):429.
3Giagounidis AA,Burk M,Meckenstock G,et al Ann Hematol.1996,73(6):297.
4Brunning RD,Flandrin G,Borowitz M,et a1.Precursor B lymphoblastic leukemia／lymphoblastic lymphoma(Precursor B—cell acute lymphoblasticleukemia)in Jaffe ES,Harris NL,Stein H,Wardiman JW.et al(ed).World Health Organization Classification of Tumours-Pathology and genetics of tumours of haernatopoietic and lymphoid tissuses.Lyon:International Agency for Research on Cancer(IARC)2001.111～114.
4Tefferi A,Vardiman JW. Classification and diagnosis of myeloproliferative neoplasms:the 2008 World Health Organization criteria and point-of-care diagnostic algorithms[J].{H}LEUKEMIA,2008,(01):14-22.
5Swerdlow S H, Campo E, llarris It, et al. Worht tteahh Organiza- tion classification of haematupoietic and lymphoid tissue[ M ]. l,y- on : IARC Press, 2008:335 - 57.
6Ahmed A, Chang C C. Chronic idiopathic myelofibrosis: clinico- pathologic features, pathogenesis, and prognosis[ J ]. Areh Pathol Lab Med, 2006,130(8) :1133 -43.
7Tefferi A. Myelofibrosis with myeloid metaplasia[ J ]. N Engl J Med, 2000,342(17) :1255 -65.
8Goh D H, Lee S H, Cho D C, et al. Chronie idiopathic myelofi- brosis presenting as cauda equina compression due to extramedul- lary hematopoiesis: a case reporl[ J]. J Korean Med Sci, 2007,22 (6) :1090 -3.
9Dameshek W. Some speculations on the dromes[J]. Blood, 1951,6(4-) :372 -5.
10Zhang B, I,ewis S M. The spleuomegaly of myelo-prolitk'rative and lymphoproliferative disorders: splenic cellularity aod vascularity [J]. EurJ Haematol, 1989,43(1):63-6.
